Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticancer drug delivery with nanoparticles.

Matteo Conti1, Valeria Tazzari, Cesare Baccini

  • 1Laboratorio di Tossicologia e Farmacologia Clinica, Ospedale S. Maria delle Croci, Ravenna, Italy. ra.hotossicologia@ausl.ra.it

In Vivo (Athens, Greece)
|January 6, 2007
PubMed
Summary

Nanoparticles are transforming drug delivery by enhancing therapeutic efficacy and enabling targeted delivery to tumors. These nanocarriers offer a potential alternative to traditional loco-regional drug delivery methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alzheimer's Disease Cerebrospinal Fluid Biomarkers Predict Survival in Progressive Supranuclear Palsy.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Frequency- and Network-Specific Changes in Functional Connectivity Reflect Pathophysiological Mechanisms across Parkinson's Disease Stages.

Annals of neurology·2026
Same author

Simultaneous orthogonal cell engineering by a single CRISPR-Cas9 polyfunctional editor.

Nature communications·2026
Same author

The Italian Taxonomic Backbone: exploiting taxonomic expertise in the country.

Biodiversity data journal·2026
Same author

Morpho-functional correlates of gait impairment in early Parkinson's disease patients: insights from a multimodal path modeling framework.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Functional brain connectivity in patients with <i>de novo</i> Parkinson's disease.

Neuroimage. Reports·2026

Area of Science:

  • Medicine
  • Biotechnology
  • Materials Science

Background:

  • Nanotechnology offers innovative nanoscale tools for medical applications.
  • Nanoparticles are emerging as powerful drug delivery vehicles.

Purpose of the Study:

  • To explore the potential of nanoparticles in revolutionizing drug delivery.
  • To investigate how nanocarriers can enhance therapeutic efficacy and enable targeted delivery.

Main Methods:

  • Engineering nanocarriers to modulate drug release and stability.
  • Designing nanoparticles to prolong drug circulation time and evade degradation.
  • Utilizing enhanced permeability and retention effect for tumor accumulation.
  • Employing active targeting with ligands for tumor-associated antigens.

Related Experiment Videos

Main Results:

  • Nanocarriers can improve drug stability and circulation time.
  • Engineered nanoparticles can protect drugs from premature degradation and elimination.
  • Nanoscale carriers demonstrate accumulation in tumor tissues via EPR effect or active targeting.
  • Potential for nanomedicine to reduce reliance on loco-regional drug delivery.

Conclusions:

  • Nanoparticles offer significant advantages for drug delivery, including enhanced efficacy and targeted action.
  • These nanocarriers show promise in overcoming limitations of conventional drug administration.
  • Nanomedicine may represent a future alternative to loco-regional drug delivery strategies.